CA
NZ
UK
AU
IND
US
Daewoong Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. filed Amendment No. 1 to Schedule 13D with the SEC on November 10, 2026, reporting the October 30, 2026 cashless exercise in full of Pre-Funded Warrants in AEON Biopharma, Inc. and the resulting changes in beneficial …
Matthew D. Mullet, President and CEO of FS Bancorp, Inc. (NASDAQ:FSBW), filed a Form 4 on November 9, 2026, disclosing a transaction dated November 6, 2026, involving the acquisition of common stock under the company's Nonqualified 2022 Stock Purchase Plan.
A Form 4 filed on November 10, 2026 with the SEC reports that Ralph E. Faison, a director of Arlo Technologies, Inc. (NASDAQ:ARLO), purchased 8,250 shares of common stock on November 9, 2026.
Phillip Dean Whittington, Chief Financial Officer of FS Bancorp, Inc. (NASDAQ:FSBW), filed a Form 4 on November 9, 2026, disclosing a transaction in the company's common stock dated November 6, 2026.
Kenneth A. Burdick, a director of LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 75,000 shares of common stock following a stock option exercise.
BlackRock, Inc. officer Rachel Lord filed a Form 144 notice of proposed sale of securities with the SEC on November 10, 2026, covering 7,000 shares of BlackRock common stock to be sold on or around November 9, 2026.
Citizens & Northern Corporation, a Pennsylvania-based bank holding company trading on NASDAQ:CZNC, filed a Form 8-K on November 10, 2026, disclosing that it posted an Investor Presentation to its website under Item 7.01 Regulation FD.
Connor, Clark & Lunn Investment Management Ltd. filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in Blue Moon Metals Inc. as of September 30, 2026.
Kimberly Pardo, listed as an investor in LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 2,216,585 shares of LifeStance common stock with an aggregate market value of $31,918,824, to be executed through Merrill Lynch …
Morgan Stanley Finance LLC filed a Free Writing Prospectus to Preliminary Pricing Supplement No. 20,022 on November 10, 2026, covering Worst-of GLD and GDX Jump Securities with an Auto-Callable Feature due December 1, 2031.
Please wait processing your request...